PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt

Area of Science:

• Molecular Biology
• Cancer Biology
• Cell Signaling

Background:

• The p53 and Akt signaling pathways play crucial, opposing roles in regulating cell survival and death during tumorigenesis.
• p53 acts as a tumor suppressor by transactivating target genes, while Akt promotes cell survival through downstream signaling.
• These pathways engage in a negative feedback loop to maintain cellular homeostasis.

Purpose of the Study:

• To identify and characterize novel p53 target genes involved in regulating the Akt pathway.
• To elucidate the mechanism by which PHLDA3 influences Akt activation and cellular processes.
• To investigate the role of PHLDA3 in tumor suppression, particularly in lung cancer.

Main Methods:

• Identification of PHLDA3 as a p53 target gene.
• Biochemical assays to assess the interaction of PHLDA3 with Akt and membrane lipids.
• Cellular experiments involving PHLDA3 ablation to evaluate Akt activity, apoptosis, and anchorage-independent growth.
• Analysis of PHLDA3 genomic locus in primary lung cancer samples.

Main Results:

• PHLDA3, a PH domain-only protein, was identified as a direct p53 target gene.
• PHLDA3 inhibits Akt activation by competing for membrane lipid binding, thus preventing Akt translocation.
• Ablation of PHLDA3 leads to increased Akt activity, reduced p53-dependent apoptosis, and enhanced anchorage-independent cell growth.
• Frequent loss of the PHLDA3 genomic locus was observed in lung cancers.

Conclusions:

• PHLDA3 acts as a tumor suppressor by inhibiting the pro-survival Akt pathway.
• This study reveals a novel mechanism of cross-talk between the p53 and Akt pathways mediated by PHLDA3.
• PHLDA3 dysfunction contributes to tumorigenesis, highlighting its potential as a therapeutic target.